The Significance of Fibroblast Growth Factor Receptor 2 Expression in Differentiation of Hepatocellular Carcinoma
Norifumi Harimoto(National Kyushu Medical Center), Yoshihiko Maehara(Kyushu University), Kenichi Taguchi, Yasushi Toh, Hiroto Kayashima(Kyushu University), Eisuke Adachi(Tokyo University of Science), Akinobu Taketomi(Hokkaido University), Yoshihisa Sakaguchi(National Kyushu Medical Center), Takeshi Okamura(National Hospital Organization Kyushu Cancer Center), Ken Shirabe(Gunma University)
Cited by 47
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244